Skip to main
RSLS
RSLS logo

ReShape Lifesciences (RSLS)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy ReShape Lifesciences (RSLS) Stock

About ReShape Lifesciences (RSLS)

Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. It focuses on therapeutic solutions that target formulations for site-targeted applications. The company was founded on January 2, 2008 and is headquartered in San Clemente, CA.
Market cap$26.08M
Today's volume21.66K
Revenue (TTM)$4.19M
Avg. daily volume316.68K
EBITDA (TTM)-$5.38M
Open$4.75
Price / earnings ratio-0.03x
Today's range$4.62 - $4.88
Debt / equity1.53x
52 week range$4.44 - $519
5 year debt / equity10.09x
Beta (LTM)-0.63x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio1.94x
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

As of Dec 14, 2025, the market cap for RSLS stock is $26.08M

The current P/E ratio for RSLS stock is -0.03

The 52-week high for RSLS stock is $519. The current RSLS stock price $undefined is 100.00% below its 52-week high

The 52-week low for RSLS stock is $4.44. The current RSLS stock price $undefined has increased 100.00% from its 52-week low

No, the RSLS stock does not pay dividends to its shareholders

How to buy RSLS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in RSLS stock

    Navigate to the Explore page. Then, type RSLS into the search bar. When you see RSLS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased RSLS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

ReShape Lifesciences Stock Earnings

The value each RSLS share was expected to gain vs. the value that each RSLS share actually gained.

ReShape Lifesciences (RSLS) reported Q1 2024 earnings per share (EPS) of -$130.50, beating estimates of -$232 by 43.75%. In the same quarter last year, ReShape Lifesciences's earnings per share (EPS) was -$2,262. ReShape Lifesciences is expected to release next earnings on , with an earnings per share (EPS) estimate of $0.

Buy ReShape Lifesciences (RSLS) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.